Peptides for sleep: what the evidence actually supports
A plain-English read of the human data behind DSIP, growth hormone-releasing peptides, and the longevity outliers.
TL;DR
- Growth hormone-releasing peptides — sermorelin, CJC-1295/ipamorelin — have the strongest human evidence for deeper sleep.
- DSIP and epitalon have older, smaller, mostly non-U.S. trials; modern replication is sparse.
- No peptide is FDA-approved for sleep; several relevant compounds are FDA Category 2 right now.
What it is
"Peptides for sleep" is shorthand for a handful of compounds linked in the literature to sleep depth or duration. The set includes growth hormone-releasing peptides (sermorelin, CJC-1295, ipamorelin), DSIP — delta sleep-inducing peptide (in plain English: a short brain peptide named after the deep-sleep brain wave) — and epitalon, a Russian-developed pineal peptide. Each compound interacts with sleep through a different door.
How it works
Imagine sleep as a layered cake. The bottom layer is slow-wave sleep, the deepest and most restorative. Growth hormone-releasing peptides raise growth hormone pulses that naturally occur during this layer, which can thicken it (Frieboes et al., Sleep, 1995). DSIP was isolated in the 1970s from rabbit brain tissue and named for the delta waves of deep sleep; it appears to interact with stress hormone signaling rather than acting as a direct sedative. Epitalon influences pineal melatonin output, the body's "lights-out" signal.
Who asks about it
People come to this topic because they have tried magnesium, melatonin, and sleep hygiene and want to know whether peptides offer a different lever. Many are in midlife, when slow-wave sleep naturally declines by about half from young adulthood to age 50.
What the research says
The growth hormone-releasing class has the most replicated human signal. Studies of GHRH and GHRH analogs report increased slow-wave sleep, especially in older adults (Steiger, Sleep Med Rev, 2007). DSIP has a small set of 1980s European trials reporting modest improvements in sleep onset and continuity in selected groups; modern, large trials are missing. Epitalon's strongest data is from a Russian research program and remains poorly replicated outside that lineage. No peptide is approved by the FDA for insomnia or sleep disorders in adults.
What to know before considering it
The sleep peptide field mixes solid mechanism with thin clinical data. Growth hormone-releasing peptides can raise IGF-1 levels; that is a normal expected effect but a reason for clinician monitoring. DSIP and epitalon are FDA Category 2 and not available from 503A pharmacies in the U.S. right now. Material sold online as "research use only" is gray-market and not regulated for human use. Any peptide protocol requires a licensed clinician evaluation.
The Halftime POV
The strongest peptide-and-sleep story is also the most regulated one: growth hormone-releasing analogs in adults with documented decline, monitored with IGF-1 labs and sleep tracking. The longevity-curio compounds (DSIP, epitalon) are interesting but not yet ready for confident recommendations. We tell readers which bucket each compound sits in — and we wait for cleaner data before recommending the others.
Related reading:
- DSIP: what the research says about the delta sleep peptide
- Sermorelin and sleep: what the data shows
- Growth hormone peptides and sleep architecture: the research
- Epitalon and sleep: the pineal-gland connection
FAQ
Q: Do peptides actually help you sleep? A: Some peptides have a plausible link to sleep. Growth hormone-releasing peptides like sermorelin and CJC-1295/ipamorelin have human data on increased slow-wave sleep — the deepest stage. DSIP and epitalon have older, mostly non-U.S. evidence and limited modern replication.
Q: What is DSIP? A: DSIP stands for delta sleep-inducing peptide. It was isolated from rabbit brain tissue in the 1970s and named after the delta brain waves of deep sleep. Human data is older and small-scale; DSIP is currently FDA Category 2 in the U.S.
Q: Are sleep peptides FDA-approved? A: No peptide is FDA-approved specifically for sleep in adults. Sermorelin is an FDA-approved active pharmaceutical ingredient with a pediatric growth-failure indication and is compounded off-label. DSIP and epitalon are Category 2 and not currently available from 503A pharmacies.
Disclaimer
As of 2026-05-13, several peptides discussed in this article — including DSIP and epitalon — are classified by the FDA as Category 2, which means they are not currently available from 503A compounding pharmacies. A February 2026 HHS announcement proposed returning these peptides to Category 1 pending formal FDA Federal Register notice. This article is educational and is not medical advice. Halftime Health only prescribes through licensed clinicians in states where our partner physicians are credentialed.
Get updates
Halftime Health is launching soon. We'll share what we learn along the way — the research, the regulations, the real-world trade-offs. Join the waitlist and we'll email you when we're live.
Sources
- Frieboes RM et al., Growth hormone-releasing peptide-6 stimulates sleep — Sleep, 1995
- Steiger A, Neurochemical regulation of sleep — Sleep Med Rev, 2007
This article discusses compounds that are currently under FDA Category 2 review (see our FDA categorization explainer). These compounds are not currently part of Halftime Health's published protocol catalog. This article is provided for educational purposes only and does not constitute medical advice or an offer to sell.
Frequently asked questions
Do peptides actually help you sleep?
Some peptides have a plausible link to sleep. Growth hormone-releasing peptides like sermorelin and CJC-1295/ipamorelin have human data on increased slow-wave sleep — the deepest stage. DSIP and epitalon have older, mostly non-U.S. evidence and limited modern replication.
What is DSIP?
DSIP stands for delta sleep-inducing peptide. It was isolated from rabbit brain tissue in the 1970s and named after the delta brain waves of deep sleep. Human data is older and small-scale; DSIP is currently FDA Category 2 in the U.S.
Are sleep peptides FDA-approved?
No peptide is FDA-approved specifically for sleep in adults. Sermorelin is an FDA-approved active pharmaceutical ingredient with a pediatric growth-failure indication and is compounded off-label. DSIP and epitalon are Category 2 and not currently available from 503A pharmacies.
Keep reading
A licensed physician can build a protocol from your own labs.
Membership from $69/mo, including your onboarding panel. Each protocol is its own monthly subscription.